TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors

NCT05650580 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma, Relapsed
Non-Hodgkin's Lymphoma Refractory
Advanced Solid Tumor

Interventions

DRUG: TR115

Sponsor

Tarapeutics Science Inc.